Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma. - Lin, Jing; Guo, Qiaojuan; Guo, Zengqing; Lu, Tianzhu; Chen, Gang; Lin, Shaojun; Chen, Mei; Chen, Chuanben; Lu, Jianping; Zong, Jingfeng; Tang, Lina; Chen, Yu; et al. (Radiation Oncology, 2022)